MYOC p.(Gln368Ter)变异与芬兰人群青光眼的关联
杂合携带者患原发性开角型青光眼(OR 3.36)、总体青光眼(OR 2.58)、疑似青光眼(OR 2.53)、剥脱性青光眼(OR 2.61)及接受青光眼相关手术(OR 5.45)的风险升高,但与正常眼压性青光眼无显著关联。
要点
- MYOC p.(Gln368Ter)杂合携带者原发性开角型青光眼风险升高(OR 3.36)。
- 该变异与剥脱性青光眼相关(OR 2.61),与正常眼压性青光眼无显著关联。
- 杂合携带者接受青光眼相关手术的OR为5.45。
核心结论
- MYOC p.(Gln368Ter)变异与芬兰人群的开角型青光眼和剥脱性青光眼相关。
- 该变异与正常眼压性青光眼的关联未能重复。
研究设计与样本
- MYOC c.1102C>T变异通过直接基因分型或微阵列填充获得,疾病终点基于全国登记数据定义。
主要发现
- MYOC p.(Gln368Ter)次要等位基因频率为0.28%。
- 杂合携带者原发性开角型青光眼OR 3.36(95%CI 2.55-4.37),总体青光眼OR 2.58(95%CI 2.12-3.13)。
- 疑似青光眼OR 2.53(95%CI 1.93-3.26),剥脱性青光眼OR 2.61(95%CI 1.60-4.02)。
- 接受青光眼相关手术OR 5.45(95%CI 2.95-9.28)。
- 正常眼压性青光眼OR 1.69(95%CI 0.72-3.35),无显著关联。
关键数值与推荐
- 杂合携带者外显率:原发性开角型青光眼5.2%,总体青光眼9.6%,疑似青光眼5.4%,剥脱性青光眼1.9%。
临床怎么用
- 在芬兰人群中检测MYOC p.(Gln368Ter)可识别开角型青光眼和剥脱性青光眼的高风险个体。
- 该变异与正常眼压性青光眼无显著关联,临床解读时应考虑青光眼亚型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The c.1102C>T, p.(Gln368Ter) variant in the myocilin (MYOC) gene is a known risk allele for glaucoma. It is the most common MYOC risk variant for glaucoma among individuals of European ancestry, and its prevalence is highest in Finland. Furthermore, exfoliation syndrome has high prevalence in Scandinavia, making the Finnish population ideal to study the association of the variant with different types of glaucoma. OBJECTIVES: To examine the association and penetrance of MYOC p.(Gln368Ter) (rs74315329) variant with different types of glaucoma in a Finnish population. DESIGN, SETTING, AND PARTICIPANTS: This genetic association study included individuals of Finnish ancestry in the FinnGen project. The participants were collected from Finnish biobanks, and the disease end points were defined using nationwide registries. The MYOC c.1102C>T variant was either directly genotyped or imputed with microarrays. Recruitment of samples to FinnGen was initiated in 2017, and data analysis was performed between December 2019 and May 2020. MAIN OUTCOMES AND MEASURES: The main outcomes were odds ratios (ORs) and penetrance with different types of glaucoma and in different age groups. RESULTS: A total of 218 792 individuals were included in this study (mean [SD] age 52.4 [17.5] years; 123 579 women [56.5%]), including 8591 (3.9%) with glaucoma, 3412 (1.6%) with primary open-angle glaucoma, 1515 (0.7%) with exfoliation glaucoma, 892 (0.4%) with normal-tension glaucoma, and 4766 (2.2%) with suspected glaucoma. The minor allele frequency of MYOC p.(Gln368Ter) was 0.28%. Individuals with the heterozygous variant had higher odds of primary open-angle glaucoma (OR, 3.36; 95% CI, 2.55-4.37), overall glaucoma (OR, 2.58; 95% CI, 2.12-3.13), suspected glaucoma (OR, 2.53; 95% CI, 1.93-3.26), exfoliation glaucoma (OR, 2.61; 95% CI, 1.60-4.02), and undergoing glaucoma-related operations (OR, 5.45; 95% CI, 2.95-9.28). The penetrance of heterozygous MYOC p.(Gln368Ter) was 5.2% in individuals with primary open-angle glaucoma, 9.6% in individuals with glaucoma, 5.4% in individuals with suspected glaucoma, and 1.9% in individuals with exfoliation glaucoma. There was no significant association with normal-tension glaucoma (OR, 1.69; 95% CI, 0.72-3.35). CONCLUSIONS AND RELEVANCE: This genetic association study found that the MYOC p.(Gln368Ter) variant was associated with exfoliation glaucoma. The association with normal-tension glaucoma could not be replicated. These findings suggest that MYOC p.(Gln368Ter) was associated with open-angle glaucoma and exfoliation glaucoma in a Finnish population.
引用
- Liuska PJ, Lemmelä S, Havulinna AS, et al. Association of the MYOC p.(Gln368Ter) Variant With Glaucoma in a Finnish Population. JAMA Ophthalmol. 2021. PMID: 34081096. doi:10.1001/jamaophthalmol.2021.1610
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。